Why Autism Diagnoses Are Rising, and Why It’s Not About Paracetamol

From evolving definitions to the neurodiversity movement, the real story of autism is one of progress, not pathology. 

Recent headlines suggesting that paracetamol causes autism have gained global attention. These claims lack scientific support, and they risk fuelling misinformation, undermining trust in healthcare, and stigmatising autistic people.

At neurobox, we offer a safe place to ask questions and to learn. We challenge misinformation with clear evidence and care, placing evidence, nuance, and lived experience at the centre of the conversation. 

No credible link between paracetamol and autism

There is no solid scientific evidence that paracetamol (also known as acetaminophen or Tylenol) causes autism. In September 2025, the UK Medicines and Healthcare products Regulatory Agency (MHRA) reaffirmed this, stating that “taking paracetamol during pregnancy remains safe and there is no evidence it causes autism in children.” The MHRA emphasised that untreated pain or fever during pregnancy can itself carry risks, making paracetamol the first-line analgesic under NHS guidance. 

Autism is not ‘caused’ by paracetamol, vaccines or parenting style. Each of these hypotheses has been robustly discredited. Research shows that autism has a strong genetic basis. Rather than being linked to a single gene, scientists believe that many different genes contribute to the likelihood of someone being autistic. 

Why autism diagnoses have increased: evidence and trends

These claim taps into a misunderstanding: yes, autism diagnoses have increased in recent decades. But the reasons lie in changing definitions, broader criteria, sociocultural shifts, and greater recognition, not in modern medicine. 

A landmark UK study by Ginny Russell et al. (covering 1998–2018) found that new autism diagnoses increased eight-fold over that period.[i]  This steep rise is often misinterpreted as an “autism epidemic,” but Russell and colleagues interpret it as largely a product of diagnostic change, catch-up, and shifting diagnostic practices. 

 

Here are key drivers of the rise: 

  1. Broadening the diagnostic net and core characteristics
  • Early descriptions of autism in the 1920s–1930s focused largely on male children with severe social impairment, minimal or no verbal language, and very high support needs. 
  • In the 1990s, Asperger’s syndrome was added to diagnostic manuals, capturing individuals with social and repetitive-behaviour differences but fluent language and average intelligence. 
  • ‘Pervasive developmental disorder – not otherwise specified’ (PDD-NOS) acted as a “safety net” diagnosis for those who didn’t neatly fit ‘classic’ autism. 
  • In 2013, the DSM-5 officially retired Asperger’s as a separate diagnosis, subsuming it (and other subtypes) under the umbrella Autism Spectrum Disorder (ASD).[ii] 
  • This consolidation effectively brought many who formerly had an Asperger’s or PDD-NOS label visibly into the autism criteria. 

For further information on the ‘core characteristics’ of autism needed for a diagnosis, please see: What is autism 

  1. Neurodiversity movement and changing culture
  • From the late 1990s onwards, the neurodiversity movement began redefining autism not as a pathology to cure, but as a form of human variation. 
  • This shift encouraged self-identification, advocacy, and destigmatisation, which in turn fuelled more assessments, more diagnoses, and more recognition of people whose traits were previously marginalised. 
  • In short, increased awareness leads to more diagnoses, which further expands awareness, a positive feedback loop often described as a “diagnosis loop.” 
  1. Gender and adult diagnosis
  • The diagnostic rise has been particularly steep among females and adults. Historically, autism was seen, even presumed to be a male experience. Many autistic girls were misdiagnosed with anxiety, OCD, or borderline personality traits, and “masked” their traits socially. 
  • As clinicians better recognise gender differences in presentation, more girls and women are being correctly diagnosed.[iii]
  • Among adults, the rise is dramatic: between 2000 and 2018, diagnoses in people without intellectual disability rose 787%, compared to 20% for those with intellectual disability. This suggests that many adults with subtler presentations are only now being identified. [iv]
  • Individuals who would previously have been recorded under intellectual or learning disability are now categorised as autistic (sometimes in addition to Intellectual Disability).[v] 

Thus, the “rise” in autism is better framed as a rediscovery and realignment, not a sudden surge of pathology. 

 

Find out more about Autism

Why false causation claims are harmful

When public figures suggest autism is caused by a common medicine like paracetamol, the damage is real: 

  • Stigma and blame: implicating a drug suggests autism is preventable or a “defect,” reinforcing shame and distancing autistic people from acceptance. 
  • Misdirection of resources: chasing imaginary causes diverts attention and funding from what matters: raising awareness, improving supports, building inclusive systems. 
  • Healthcare distrust: undermining confidence in safe, evidence-based medicines can lead to avoidable harms, especially when pain or fever need treatment. 
neurobox Autism Icon - 5 different shades of purple in a circle

What Autism is

Autism is part of an individual’s experience of being in the world. It cannot be “cured.” But it does not require a cure. Many autistic people lead fulfilling lives when afforded respect, appropriate support, and accommodation. Because autism is a continuum, each individual has a unique combination of traits, strengths, challenges, and support needs. What works for one person may not suit another. 

Far from being a medical “problem” to eradicate, autism should be embraced as part of human cognitive diversity. The goal should be increasing access and agency, not scapegoating or stigma. 

Autism is not a mystery to be solved, but a difference to be understood. The real challenge is not chasing false causes but creating a society where autistic people are valued, included, and supported. 

Find out more about Autism

About the author

Deb Leveroy - a female with short brown hair wearing a grey waterfal jumper smiling at the camera
Dr Deborah Leveroy
Head of Research

Deborah is a practitioner and academic with 15 years of experience researching and working in the neurodiversity and disability field. Her work has been published in several Routledge peer-reviewed journals, the British Dyslexia Association handbook, and People Management magazine. Deborah has a PhD in dyslexia from the University of Kent. She brings her varied background to her role, having worked as a disability advisor, strategy coach, study skills tutor, university lecturer and theatre practitioner.

Deborah is responsible for developing and implementing our research strategy and approach, that is trauma-informed, relational and multi-disciplinary. Core activities include impact evaluation, insight panels, internal knowledge exchange and research partnerships.